Overview

A Study of an Investigational Medication for the Treatment of Secondary Hyperparathyroidism in Patients on Dialysis

Status:
Completed
Trial end date:
2003-07-01
Target enrollment:
0
Participant gender:
All
Summary
This 6 month study will assess an investigational medication for patients on dialysis with secondary hyperparathyroidism. The study will look at the effects on parathyroid hormone, calcium and phosphorus levels.
Phase:
Phase 3
Accepts Healthy Volunteers?
No
Details
Lead Sponsor:
Amgen
Treatments:
Cinacalcet
Cinacalcet Hydrochloride
Criteria
Patients must be receiving hemodialysis; have elevated parathyroid hormone levels; not be
pregnant or nursing; and not have had a heart attack in the last 3 months.